Interferon Therapy in Neoplastic Disease
- 12 January 1978
- journal article
- case report
- Published by Wiley in Acta Medica Scandinavica
- Vol. 204 (1-6), 471-476
- https://doi.org/10.1111/j.0954-6820.1978.tb08475.x
Abstract
The treatment of 10 patients having neoplastic disease with exogenous i.m. interferon therapy is described. The interferon given is partially purified interferon produced from human leukocytes. Sendai virus is used as interferon inductor. The patients reported in this paper have been on treatment for periods of 2-28 months. Apart from initial periods of fever, no side-effects have been recorded. Patients suffering from bladder papillomas have shown partial regression after a few months of therapy. The other cases treated are too few to warrant any conclusions, but the therapy does seem to have been beneficial.Keywords
This publication has 12 references indexed in Scilit:
- Production and preparation of human leukocyte interferonPharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors, 1977
- INTERFERON SKIN REACTIVITY AND PYREXIAL REACTIONSThe Lancet, 1977
- Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue cultureInternational Journal of Cancer, 1977
- Acute Infections in Interferon-Treated Patients with Osteosarcoma: Preliminary Report of a Comparative StudyThe Journal of Infectious Diseases, 1976
- Growth inhibition of human lymphoblastoid Daudi cellsin vitro by interferon preparationsArchiv für die gesamte Virusforschung, 1976
- Interferon Therapy in Hodgkin's DiseaseActa Medica Scandinavica, 1976
- INTERFERON IN ACUTE LEUKÆMIA IN CHILDRENThe Lancet, 1974
- Antitumor Effects Of InterferonAdvances in Cancer Research, 1973
- Virus interference. I. The interferonProceedings of the Royal Society of London. B. Biological Sciences, 1957